Roche Blood Test for Lp(a) Designated Breakthrough Device

The Tina-quant Lp(a) RxDx assay identifies adults with elevated Lp(a) levels who might benefit from innovative lipid-lowering therapies currently in development.

Related Keywords

United States , ,Drug Administration ,Amgen ,Silence Therapeutics ,